Nicolai Mader
8PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Jan 23, 2024
Safety and Efficacy of Selective Internal Radionuclide Therapy with <sup>90</sup>Y Glass Microspheres in Patients with Progressive Hepatocellular Carcinoma after the Failure of Repeated Transarterial Chemoembolization.Alexander Bellendorf, Nicolai Mader, Stefan P Mueller
|Sep 28, 2023
Intermittent Radioligand Therapy with <sup>177</sup>Lu-PSMA-617 for Oligometastatic Castration-Resistant Prostate Cancer.Nicolai Mader, Christina Schoeler, Niloufar Pezeshkpour
|Aug 12, 2023
Impact of [<sup>177</sup>Lu]Lu-PSMA-617 Radioligand Therapy on Reference Organ Uptake Assessed by [<sup>68</sup>Ga]Ga-PSMA-11-PET/CT.Daniel Groener, Jennifer Wichert, Magdalena Adams
|Jan 21, 2023
Baseline [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT before [<sup>177</sup>Lu]Lu-PSMA-617 Radioligand Therapy: Value of PSMA-Uptake Thresholds in Predicting Targetable Lesions.Daniel Groener, Sina Schneider, Justus Baumgarten
|Feb 15, 2022
Safety and Efficacy of <sup>177</sup>Lutetium-PSMA-617 Radioligand Therapy Shortly after Failing <sup>223</sup>Radium-Dichloride.Justus Baumgarten, Daniel Groener, Christina Nguyen Ngoc
|Oct 23, 2021
Prophylactic Peripheral Blood Stem Cell Collection in Patients with Extensive Bone-Marrow Infiltration of Neuroendocrine Tumours Prior to Peptide Receptor Radionuclide Therapy with <sup>177</sup>Lu-DOTATATE.Amir Sabet, Nicolai Mader, Jörg Thomas Bittenbring
Pageof 2
